1.The application effect of Generative Pre-Treatment Tool of Skeletal Pathology in functional lumbar spine radiographic analysis.
Yilizati YILIHAMU ; K ZHAO ; H ZHONG ; S Q FENG
Chinese Journal of Surgery 2025;63(10):936-941
Objective: To investigate the application effectiveness of the artificial intelligence(AI) based Generative Pre-treatment tool of Skeletal Pathology (GPTSP) in measuring functional lumbar radiographic examinations. Methods: This is a retrospective case series study,reviewing the clinical and imaging data of 34 patients who underwent lumbar dynamic X-ray radiography at Department of Orthopedics, the Second Hospital of Shandong University from September 2021 to June 2023. Among the patients, 13 were male and 21 were female, with an age of (68.0±8.0) years (range:55 to 88 years). The AI model of the GPTSP system was built upon a multi-dimensional constrained loss function constructed based on the YOLOv8 model, incorporating Kullback-Leibler divergence to quantify the anatomical distribution deviation of lumbar intervertebral space detection boxes, along with the introduction of a global dynamic attention mechanism. It can identify lumbar vertebral body edge points and measure lumbar intervertebral space. Furthermore, spondylolisthesis index, lumbar index, and lumbar intervertebral angles were measured using three methods: manual measurement by doctors, predefined annotated measurement, and AI-assisted measurement. The consistency between the doctors and the AI model was analyzed through intra-class correlation coefficient (ICC) and Kappa coefficient. Results: AI-assisted physician measurement time was (1.5±0.1) seconds (range: 1.3 to 1.7 seconds), which was shorter than the manual measurement time ((2 064.4±108.2) seconds,range: 1 768.3 to 2 217.6 seconds) and the pre-defined annotation measurement time ((602.0±48.9) seconds,range: 503.9 to 694.4 seconds). Kappa values between physicians' diagnoses and AI model's diagnoses (based on GPTSP platform) for the lumbar slip index, lumbar index, and intervertebral angles measured by three methods were 0.95, 0.92, and 0.82 (all P<0.01), with ICC values consistently exceeding 0.90, indicating high consistency. Based on the doctor's manual measurement, compared with the predefined label measurement, altering AI assistance, doctors measurement with average annotation errors reduced from 2.52 mm (range: 0.01 to 6.78 mm) to 1.47 mm(range: 0 to 5.03 mm). Conclusions: The GPTSP system enhanced efficiency in functional lumbar analysis. AI model demonstrated high consistency in annotation and measurement results, showing strong potential to serve as a reliable clinical auxiliary tool.
Humans
;
Female
;
Retrospective Studies
;
Male
;
Lumbar Vertebrae/diagnostic imaging*
;
Middle Aged
;
Aged
;
Aged, 80 and over
;
Artificial Intelligence
;
Radiography
;
Spondylolisthesis/diagnostic imaging*
2.Investigation of a measles outbreak caused by genotype D8 virus in Pinghu city of Zhejiang province, 2017.
R YAN ; B HE ; F Y YAO ; Z L XIANG ; H Q HE ; S Y XIE ; Y FENG
Chinese Journal of Epidemiology 2018;39(3):333-336
Objective: To investigate the epidemiological characteristics of measles outbreak caused by genotype D8 virus in Pinghu city of Zhejiang province, and provide evidence for the control of the outbreak. Methods: The measles outbreak data were collected through National Measles Surveillance System. The outpatient records and admission records were checked, field investigation and outbreak response were conducted. Blood samples in acute phase and swab specimens were collected from the patients for laboratory testing, including serology test, RNA extraction and amplification, measles virus isolation and genotype identification. Software SPSS 17.0 and Excel 2016 were used for data analysis. Results: A total of 10 confirmed measles cases were reported in Pinghu city, and 8 cases were aged >40 years. Six blood samples were collected, in which 5 were measles D8 virus positive and 1 was negative in measles virus detection. There were epidemiological links among 10 cases which occurred in a factory, a hospital and a family at the same time. There was no statistical difference in symptoms among cases caused by D8 virus and H1a virus. After the emergent measles vaccination, the measles outbreak was effectively controlled. Conclusion: Untimely response due to the uneasy detection of measles cases in the early stage, nosocomial infection and weak barrier of measles immunity in adults might be the main reasons for this outbreak. Measles vaccination is effective in the prevention of measles D8 virus infection. It is necessary to strengthen measles genotype monitoring for the tracing of infection source and control of outbreaks.
Adult
;
Amplified Fragment Length Polymorphism Analysis
;
Child
;
Cross Infection
;
Disease Outbreaks
;
Genotype
;
Hospitalization
;
Humans
;
Measles/virology*
;
Measles virus/isolation & purification*
;
Outpatients
;
Population Surveillance
;
RNA, Viral/genetics*
;
Sequence Analysis, DNA
3.Dynamic variations of BMI and influencing factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Liuzhou, Guangxi Zhuang Autonomous Region, 2013-2014.
H H CHEN ; B T FU ; Q Y ZHU ; H X LU ; L H LUO ; L CHEN ; X H LIU ; X J ZHOU ; J H HUANG ; X X FENG ; G S SHAN ; Z Y SHEN
Chinese Journal of Epidemiology 2018;39(4):487-490
Objective: To understand the dynamic variation of BMI and influencing factors among HIV/AIDS patients receiving highly active anti-retroviral therapy (HAART) in Liuzhou, Guangxi Zhuang Autonomous Region (Guangxi). Methods: HIV/AIDS patients receiving HAART for the first time since 1 January 2013 were selected. Data on BMI was analyzed among patients receiving HAART at baseline,6 months and 12 months after treatment. By using the general linear model repeated measures of analysis of variance, BMI dynamic variations and influencing factors were described and analyzed. Results: The average BMI of 2 871 patients at baseline, 6th months and 12th months appeared as (20.65±3.32), (20.87±3.22) and (21.18±3.20), respectively, with differences all statistically significant (F=18.86, P<0.001). BMI were increasing over time with treatments (F=37.25, P<0.001). Main influencing factors were noticed as: age, sex, marital status, baseline data of CD(4)(+)T cells and the WHO classification on clinical stages. Conclusions: Higher proportion of BMI malnutrition counts was seen among patients before receiving HAART in Liuzhou. BMI of the patients that were on HAART seemed being influenced by many factors. It is necessary to select appropriate treatment protocols on different patients so as to improve the nutritional status of the patients.
Acquired Immunodeficiency Syndrome
;
Antiretroviral Therapy, Highly Active
;
Body Mass Index
;
CD4 Lymphocyte Count
;
China/epidemiology*
;
HIV Infections/drug therapy*
;
Humans
;
Linear Models
;
Marital Status
;
Nutritional Status
;
T-Lymphocytes
4.Related factors and interaction on HIV/HCV co-infection of patients access to methadone maintenance treatment.
T YAO ; D FENG ; M H PAN ; Y P CHENG ; C X LI ; J WANG ; Y L FENG ; J SHI ; T SU ; Q CHEN ; S SHI ; S P WANG
Chinese Journal of Epidemiology 2018;39(5):631-635
Objective: To estimate the prevalence of HIV/HCV co-infection and explore the influence factors and their interaction on HIV/HCV co-infection of patient's access to methadone maintenance treatment (MMT). Methods: A face to face interviews were conducted among 750 patients at two MMT clinics in Guangxi Zhuang Autonomous Region. The questionnaires information included demographic characteristics, HIV and HCV infection status, history of drug abuse, urine test for morphine, high risk sex behaviors, needle sharing, dropped out etc. Methods of χ(2) test one-way, multivariate logistic regression and interactions were used to analyze the related factors of HIV/HCV co-infection. Results: The study subjects included 750 participants, 18.31% (127/691) of patients were co-infected with HIV and HCV. The HIV/HCV co-infection rate in patients who shared needles with others or dropped out of treatment was 35.84% (81/226) and 19.88% (64/322) respectively, which were higher than those who have never shared needles or dropped out (9.89%, 46/465 and 17.07%, 63/369). Logistic regression analysis results showed that after adjusted for confounding factors, patients who shared needles (OR=4.50, 95%CI: 2.72-7.43) and dropped out of treatment (OR=1.71, 95%CI: 1.04-2.80) were more likely to be infected with HIV/HCV. Interaction analysis showed that sharing needles and dropping out of treatment exist additive effect on co-infection of HIV and HCV (RERI=4.21, AP=0.44, SI=1.95). Conclusions: Needle sharing and dropping out of treatment are associated with HIV/HCV co-infection. Health education, psychological counseling and other measures should be taken to reduce needle sharing and dropping out of MMT.
China/epidemiology*
;
Coinfection/epidemiology*
;
Female
;
HIV Infections/epidemiology*
;
Hepatitis C/diagnosis*
;
Humans
;
Logistic Models
;
Male
;
Methadone/therapeutic use*
;
Morphine
;
Needle Sharing
;
Opiate Substitution Treatment
;
Prevalence
;
Risk Factors
;
Sexual Behavior
;
Substance Abuse, Intravenous/drug therapy*
;
Substance-Related Disorders
5.Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants.
Z Q YANG ; H Y HAO ; X H SHI ; Z D FU ; F ZHANG ; X F WANG ; X X XU ; B WANG ; H X WEN ; S Y FENG ; B WANG ; S P WANG
Chinese Journal of Epidemiology 2018;39(6):805-809
Objective: To explore the relationship between the status of HBsAg-positive infection of mothers and the non/low-response to hepatitis B vaccine of their infants. Methods: A total of 225 pairs of mothers and their infants were recruited in our cohort from June 2011 to July 2013. Infants were given three doses of hepatitis B vaccine at hour 24, first month and month 6(t)h respectively and were followed up for one year after birth. HBV serological markers and HBV DNA in the peripheral blood of both mothers and infants were detected by Electro-chemiluminescence immunoassay and fluorescence quantitative Polymerase Chain Reaction. Results: Six HBV infection models were detected in HBsAg-positive mothers, and "HBsAg (+), HBeAg (+), anti-HBc (+)" (model one) and "HBsAg (+), anti-HBe (+), anti-HBc (+)" (model two) accounted for 92.5%(208/225) of all the models. Rate of non/low-response to hepatitis B vaccine in infants born to mothers in model one was lower than those in model two, the differences are statistically significant (χ(2)=4.80, P=0.029). The rate of non/low-response to hepatitis B vaccine in infants showed a downward trend with the rising of HBeAg level in their mothers (χ(2)=4.86, P=0.028). Results from the unconditional logistic regression analysis showed that the HBeAg of the HBsAg-positive mothers was significantly correlated with the low risk of non/low-response to hepatitis B vaccine in infants (OR=0.598, 95%CI: 0.378-0.947). The positive rate of serum HBV DNA in HBsAg-positive mothers was 54.2%, while the rate of non/low-response to hepatitis B vaccine in infants born to HBV DNA positive mothers was similar to those infants born to HBV DNA negative mothers (χ(2)=0.22, P=0.640). Conclusions: "HBsAg (+), HBeAg (+), anti-HBc (+)" and "HBsAg (+), anti-HBe(+), anti-HBc (+)" were the common models seen in HBsAg-positive mothers, and the rate of non/low-response to hepatitis B vaccine was different between the two models. HBeAg of HBsAg-positive mothers might have positive effects on the immune response to hepatitis B vaccine in infants but the mechanisms remained not clear. HBV DNA of the HBsAg-positive mothers did not seem to be correlated with the immune response to hepatitis B vaccine in infants.
Adult
;
Biomarkers/blood*
;
DNA, Viral/blood*
;
Diagnostic Tests, Routine
;
Female
;
Hepatitis B/prevention & control*
;
Hepatitis B Antibodies/blood*
;
Hepatitis B Surface Antigens/blood*
;
Hepatitis B Vaccines/pharmacology*
;
Hepatitis B e Antigens/blood*
;
Hepatitis B virus/isolation & purification*
;
Humans
;
Infant
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Mothers
;
Pregnancy
;
Pregnancy Complications, Infectious/virology*
6.General plan of Shanghai Diet and Health Survey.
Z N ZHU ; Y LU ; C F WU ; S R ZOU ; H LIU ; C F WANG ; B Z LUO ; H T YU ; M MI ; G Q WANG ; L B XIONG ; W J WANG ; C Y LUO ; J J ZANG ; Z Y WANG ; X D JIA ; X G FENG ; C Y GUO ; F WU
Chinese Journal of Epidemiology 2018;39(7):876-879
Shanghai Diet and Health Survey (SDHS) was designed to prospectively access local residents' food consumption, energy and nutrient intake, related chemical contaminant exposure, and the seasonal change trend to explore the relationship of diet with health. Data from SDHS can be used as fundamental information and scientific evidences for the development of local nutrition and food safety policies.
China
;
Diet
;
Energy Intake
;
Health Surveys
;
Nutrition Policy
;
Nutrition Surveys
7.Prevalence of attention deficit and hyperactivity disorder in children in China: a systematic review and Meta-analysis.
S M LI ; W FENG ; F FANG ; X H DONG ; Z J ZHANG ; Q Q YANG
Chinese Journal of Epidemiology 2018;39(7):993-998
Objective: To understand the prevalence of attention deficit and hyperactivity disorder (ADHD) in children in China and provide scientific basis for early prevention and treatment of ADHD in children. Methods: A systematic literature retrieval was conducted by using CNKI, Wanfang data, CBM and VIP databases for the information about the prevalence of ADHD in children in China published from 1979 to 2017. Pubmed database was used to retrieve the literatures about ADHD prevalence in children in China published from 1946 to 2017. The quality of literature was evaluated based on the cross-sectional study criteria according to STROBE statement. Stata 12.0 was used for combined prevalence and subgroup analyses, including gender, regions, publication year, diagnostic criteria, sampling methods, and so on. Egger testing and the evaluation of funnel graph were used to evaluate the publication bias of these literatures, and sensitivity analysis was done by using different models and eliminating the influence of any one of these articles on combined effect value. Results: Twenty articles were included. The total sample size was 88 755, including 46 216 boys and 42 539 girls. The prevalence of ADHD in children in China was 5.6% (95%CI: 5.0%-6.3%). The prevalence was 7.7% (95%CI: 6.7%-8.8%) in boys and 3.4% (95%CI: 3.0%-3.8%) in girls, the difference was statistically significant (P<0.05). No statistically significance difference in the ADHD prevalence was observed between different regions publication years, diagnostic criteria and sampling methods. Conclusions: The prevalence of ADHD in children in China was high, and boys tended to have a higher prevalence compared with girls. Appropriate screening methods for early detection and intervention conduction of ADHD should be taken among children in China.
Attention Deficit Disorder with Hyperactivity/epidemiology*
;
Child
;
China/epidemiology*
;
Female
;
Humans
;
Male
;
Prevalence
;
Sex Distribution
8.Current situation and related policies on the implementation and promotion of influenza vaccination, in China.
Z B PENG ; D Y WANG ; J YANG ; P YANG ; Y Y ZHANG ; J CHEN ; T CHEN ; Y M ZHENG ; J D ZHENG ; S Q JIANG ; L L XU ; M KANG ; Y QIN ; M J ZHAO ; Z J LI ; L Z FENG
Chinese Journal of Epidemiology 2018;39(8):1045-1050
Influenza can be prevented through annual appropriate vaccination against the virus concerned. In China, influenza vaccine is categorized as "Class Ⅱ" infectious diseases which the cost is paid out of the user's pockets. The annual coverage of influenza vaccination had been 2%-3%. The main reasons for the low coverage would include the following factors: lacking awareness on both the disease and vaccine, poor accessibility of vaccination service, and the cost of vaccination. To reduce the health and economic burden associated with influenza, comprehensive policies should be improved, targeting the coverage of seasonal influenza vaccination. These items would include: ① Different financing reimbursement schemes and mechanisms to improve the aspiration on vaccination and on the vaccine coverage in high-risk groups, as young children, elderly, people with underlying medical conditions; ② to ameliorate equality of vaccination services; ③ to improve knowledge of the health care workers (HCWs) and the public on influenza and related vaccines; ④ to improve clinical and preventive medical practice and vaccination among HCWs through revising clinical guidelines, pathway and consensus of experts; ⑤ to provide more convenient, accessible and normative vaccination service system; ⑥ to strengthen research and development as well as marketing on novel influenza vaccines; ⑦ to revise items regarding the contraindication for influenza vaccine on pregnancy women, stated in the Chinese Pharmacopoeia.
Aged
;
Awareness
;
Child
;
China
;
Costs and Cost Analysis
;
Female
;
Health Knowledge, Attitudes, Practice
;
Health Personnel
;
Health Promotion/methods*
;
Humans
;
Influenza Vaccines/economics*
;
Influenza, Human/prevention & control*
;
Male
;
Pregnancy
;
Vaccination
9.Technical guidelines for seasonal influenza vaccination in China, 2018-2019.
L Z FENG ; Z B PENG ; D Y WANG ; P YANG ; J YANG ; Y Y ZHANG ; J CHEN ; S Q JIANG ; L L XU ; M KANG ; T CHEN ; Y M ZHENG ; J D ZHENG ; Y QIN ; M J ZHAO ; Y Y TAN ; Z J LI ; Z J FENG
Chinese Journal of Epidemiology 2018;39(11):1413-1425
Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and its complications. Currently, China has licensed trivalent (IIV3) and quadrivalent inactivated influenza vaccine (IIV4), including split-virus influenza vaccine and subunit vaccine. In most parts of China, influenza vaccine is a category Ⅱ vaccine, which means influenza vaccination is voluntary, and recipients need to pay for it. To strengthen the technical guidance for prevention and control of influenza and the operational research on influenza vaccination in China, the National Immunization Advisory Committee (NIAC), Influenza Vaccine Technical Working Group (TWG), updated the 2014 technical guidelines and compiled the "Technical guidelines for seasonal influenza vaccination in China (2018-2019)" , based on most recent existing scientific evidences. The main updates include: epidemiology and disease burden of influenza, types of influenza vaccines, northern hemisphere influenza vaccination composition for the 2018-2019 season, and, IIV3 and IIV4 vaccines'major immune responses, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. The recommendations include: Points of Vaccination clinics (PoVs) should provide influenza vaccination to all persons aged 6 months and above who are willing to be vaccinated and do not have contraindications. No preferential recommendation is made for any influenza vaccine product for persons who can accept ≥1 licensed, recommended, and appropriate products. To decrease the risk of severe infections and complications due to influenza virus infection among high risk groups, the recommendations prioritize seasonal influenza vaccination for children aged 6-60 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, the family members and caregivers of infants <6 months of age, and pregnant women or women who plan to pregnant during the influenza season. Children aged 6 months to 8 years old require 2 doses of influenza vaccine administered a minimum of 4 weeks apart during their first season of vaccination for optimal protection. If they were vaccinated in previous influenza season, 1 dose is recommended. People ≥ 9 years old require 1 dose of influenza vaccine. It is recommended that people receive their influenza vaccination by the end of October. Influenza vaccination should be offered as soon as the vaccination is available. Influenza vaccination should continue to be available for those unable to be vaccinated before the end of October during the whole season. Influenza vaccine is also recommended for use in pregnant women during any trimester. These guidelines are intended for CDC members who are working on influenza control and prevention, PoVs members, healthcare workers from the departments of pediatrics, internal medicine, and infectious diseases, and members of maternity and child care institutions at all levels.
Adult
;
Child
;
Child, Preschool
;
China
;
Female
;
Guidelines as Topic
;
Humans
;
Infant
;
Influenza Vaccines/administration & dosage*
;
Influenza, Human/prevention & control*
;
Pregnancy
;
Seasons
;
Vaccination

Result Analysis
Print
Save
E-mail